Nephrocare Health Services Limited has informed the Exchange regarding Notice of Postal Ballot
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nephrocare Health Services Limited has initiated a Postal Ballot process (via remote e-voting through NSDL) seeking shareholder approval on two items. Item 1 (Special Resolution): Re-appointment of Mr. Om Prakash Manchanda (DIN: 02099404), former Managing Director of Dr. Lal Path Labs, as an Independent Director for a second term of 3 consecutive years from February 11, 2026 to February 10, 2029; he was last paid Rs. 1.50 million in sitting fees and commission for FY 2024-25 and attended 6 of 8 board meetings. Item 2 (Ordinary Resolution): Appointment of M/s Makarand M. Joshi & Co., Practising Company Secretaries, as Secretarial Auditor for a 5-year term (April 1, 2025 to March 31, 2030) at a remuneration of Rs. 2,75,000 per annum plus applicable taxes and out-of-pocket expenses. The remote e-voting window is from 9:00 a.m. IST on January 8, 2026 to 5:00 p.m. IST on February 6, 2026, with the cut-off date for eligibility set as January 2, 2026. Results will be announced within two working days after closure of voting.
This is a routine corporate governance exercise with no material financial or strategic impact on shareholders. Investors holding shares as on January 2, 2026 should exercise their voting rights on both resolutions; both are standard items typically expected to pass without controversy.